Heron Therapeuti Stock Fundamentals
| HRTX Stock | USD 2.65 0.15 5.36% |
Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.
At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.1 M in 2024, despite the fact that Operating Income is likely to grow to (105.1 M). Heron | Select Account or Indicator |
Heron Therapeuti Company Profit Margin Analysis
Heron Therapeuti's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Heron Therapeuti Profit Margin | (0.87) % |
Most of Heron Therapeuti's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Heron Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Heron Therapeuti has a Profit Margin of -0.8702%. This is 92.24% lower than that of the Biotechnology sector and 96.22% lower than that of the Health Care industry. The profit margin for all United States stocks is 31.48% lower than that of the firm.
Heron Therapeuti Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Heron Therapeuti's current stock value. Our valuation model uses many indicators to compare Heron Therapeuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heron Therapeuti competition to find correlations between indicators driving Heron Therapeuti's intrinsic value. More Info.Heron Therapeuti is rated # 5 in return on equity category among related companies. It is rated # 4 in return on asset category among related companies . At this time, Heron Therapeuti's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Heron Therapeuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Heron Therapeuti's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heron Therapeuti's earnings, one of the primary drivers of an investment's value.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Heron Fundamentals
| Return On Equity | -24.09 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.87) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 497.59 M | ||||
| Shares Outstanding | 150.33 M | ||||
| Shares Owned By Insiders | 0.94 % | ||||
| Shares Owned By Institutions | 76.02 % | ||||
| Number Of Shares Shorted | 25.43 M | ||||
| Price To Earning | (5.15) X | ||||
| Price To Book | 12.60 X | ||||
| Price To Sales | 3.44 X | ||||
| Revenue | 127.04 M | ||||
| Gross Profit | (50.51 M) | ||||
| EBITDA | (107.72 M) | ||||
| Net Income | (110.56 M) | ||||
| Cash And Equivalents | 83.54 M | ||||
| Cash Per Share | 0.81 X | ||||
| Total Debt | 179.63 M | ||||
| Debt To Equity | 6.64 % | ||||
| Current Ratio | 1.77 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (58.79 M) | ||||
| Short Ratio | 15.63 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Price To Earnings To Growth | (0.18) X | ||||
| Target Price | 6.75 | ||||
| Number Of Employees | 126 | ||||
| Beta | 1.71 | ||||
| Market Capitalization | 398.37 M | ||||
| Total Asset | 222.51 M | ||||
| Retained Earnings | (1.91 B) | ||||
| Working Capital | 109.09 M | ||||
| Current Asset | 134.75 M | ||||
| Current Liabilities | 19.73 M | ||||
| Net Asset | 222.51 M |
About Heron Therapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 3.2 M | 3.3 M | |
| Total Revenue | 127 M | 133.4 M | |
| Cost Of Revenue | 65.1 M | 68.4 M | |
| Stock Based Compensation To Revenue | 0.26 | 0.25 | |
| Sales General And Administrative To Revenue | 0.39 | 0.37 | |
| Research And Ddevelopement To Revenue | 0.44 | 0.42 | |
| Capex To Revenue | (0.01) | (0.01) | |
| Revenue Per Share | 0.92 | 0.87 | |
| Ebit Per Revenue | (0.87) | (0.91) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Heron Therapeuti Piotroski F Score and Heron Therapeuti Altman Z Score analysis. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.